Uremic toxins in the progression of chronic kidney disease and cardiovascular disease: mechanisms and therapeutic targets

YJ Lim, NA Sidor, NC Tonial, A Che, BL Urquhart - Toxins, 2021 - mdpi.com
Chronic kidney disease (CKD) is a progressive loss of renal function. The gradual decline in
kidney function leads to an accumulation of toxins normally cleared by the kidneys, resulting …

Gut-derived protein-bound uremic toxins

AL Graboski, MR Redinbo - Toxins, 2020 - mdpi.com
Chronic kidney disease (CKD) afflicts more than 500 million people worldwide and is one of
the fastest growing global causes of mortality. When glomerular filtration rate begins to fall …

Interaction between a water-soluble anionic porphyrin and human serum albumin unexpectedly stimulates the aggregation of the photosensitizer at the surface of the …

A Costa-Tuna, OA Chaves, RJS Loureiro… - International Journal of …, 2024 - Elsevier
Abstract The 5, 10, 15, 20-tetrakis (2, 6-difluoro-3-sulfophenyl) porphyrin (TDFPPS 4) was
reported as a potential photosensitizer for photodynamic therapy. The capacity of the …

Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease

JD Ravid, MH Kamel, VC Chitalia - Nature Reviews Nephrology, 2021 - nature.com
Chronic kidney disease (CKD) is characterized by the retention of a myriad of solutes termed
uraemic (or uremic) toxins, which inflict damage to several organs, including the …

Insight into the binding mechanism of imipenem to human serum albumin by spectroscopic and computational approaches

MT Rehman, H Shamsi, AU Khan - Molecular Pharmaceutics, 2014 - ACS Publications
The mechanism of interaction between imipenem and HSA was investigated by various
techniques like fluorescence, UV–vis absorbance, FRET, circular dichroism, urea …

MARK4 inhibited by AChE inhibitors, donepezil and Rivastigmine tartrate: insights into Alzheimer's disease therapy

A Shamsi, S Anwar, T Mohammad, MF Alajmi… - Biomolecules, 2020 - mdpi.com
Microtubule affinity-regulating kinase (MARK4) plays a key role in Alzheimer's disease (AD)
development as its overexpression is directly linked to increased tau phosphorylation …

Biophysical and molecular docking insight into the interaction of cytosine β-D arabinofuranoside with human serum albumin

P Alam, SK Chaturvedi, T Anwar, MK Siddiqi… - Journal of …, 2015 - Elsevier
Interaction of pharmacologically important anticancer drug cytosine β-D arabinofuranoside
with human serum albumin (HSA) at physiological pH 7.4 has been studied by utilizing …

Myricetin inhibits breast and lung cancer cells proliferation via inhibiting MARK4

S Anwar, S Khan, F Anjum, A Shamsi… - Journal of Cellular …, 2022 - Wiley Online Library
Identifying novel molecules as potential kinase inhibitors are gaining significant attention
globally. The present study suggests Myricetin as a potential inhibitor of microtubule‐affinity …

Understanding the binding between Rosmarinic acid and serum albumin: In vitro and in silico insight

A Shamsi, A Ahmed, MS Khan, M Al Shahwan… - Journal of Molecular …, 2020 - Elsevier
Rosmarinic acid (RA) is a natural product that is increasingly being used in food industries
and cosmetic industries. Drug pharmacokinetics is affected upon binding with protein, thus …

Biophysical characterization of the interaction between a transport human plasma protein and the 5, 10, 15, 20-tetra (pyridine-4-yl) porphyrin

OA Chaves, BA Iglesias, C Serpa - Molecules, 2022 - mdpi.com
The interaction between human serum albumin (HSA) and the non-charged synthetic
photosensitizer 5, 10, 15, 20-tetra (pyridine-4-yl) porphyrin (4-TPyP) was evaluated by in …